Ireland
--:--IST
Recruiting Not applicable

Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis

NCT05748015 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2021-03-04
Last updated
2026-04-17

Condition(s) studied

Multiple Sclerosis

Investigational drug(s) / intervention(s)

quantification of sensory and autonomic small nerve fibers by punch skin biopsyCardiovascular Reflexes testingAdministration of clinical scales evaluating autonomic symptoms, pain small fiber neuropathy symptoms

quantification of sensory and autonomic small nerve fibers by punch skin biopsy: We'll perform a punch skin biopsy of 3mm from thigh, leg and fingertip and we'll quantify peripheral sensory and autonomic nerve fibers.

Cardiovascular Reflexes testing: Cardiovascular reflex tests including deep breathing, head-up Tilt, standing, isometric exercises, mental arithmetic and Valsalva maneuver.

Administration of clinical scales evaluating autonomic symptoms, pain small fiber neuropathy symptoms: We'll characterize patients' symptoms through the administration of clinical scales such as: COMPASS 31 autonomic symptoms scale; Small Fiber Neuropathy Symptom Inventory Questionnaire (SFN-SIQ), the Pain Detect Questionnaire and the Total neuropathy score

Study summary

The goal of this interventional non-pharmacological study is to evaluate the involvement of the autonomic nervous system in patients with relapsing-remitting and primary progressive multiple sclerosis.

The main questions it aims to answer are:

* Is it possible to define the characteristics of dysautonomia to improve treatment on patients with multiple sclerosis through the management of conditions such as orthostatic hypotension or thermoregulation disorders that inevitably condition the patient's life and the response to rehabilitation ?
* Does the severity of the functional alterations correlate with impairment of small somatic and autonomic cutaneous nerve fibers in patients with multiple sclerosis ?
* How much the involvement of the autonomic nervous system affects the clinical history and progression of the disease ?
* Do different clinical variants of multiple sclerosis manifest with different patterns of involvement of the sensory-autonomic nervous system ?

Participants will be hospitalized in Maugeri Clinical Institute of Telese Terme for a rehabilitation treatment. Patients will perform a sensory and autonomic functional study and a morphological analysis of cutaneous nerves through skin biopsy.

Researchers will compare results between the two groups (relapsing-remitting and primary progressive) and between patients and data from control subjects.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * diagnosis of relapsing-remitting and primary progressive multiple sclerosis. Exclusion Criteria: * other forms of multiple sclerosis, * known other neurological disorders * assumption of potentially neurotoxic substances or drugs.

Primary outcome measure(s)

  • Cardiovascular reflex test — At the recruitment
    Assessment of Cardiovascular reflex responses to physical challenges.
  • Sudomotor function test — At the recruitment
    Assessment of postganglionic sudomotor function through dynamic sweat test

Trial sites (2)

FacilityCityRegionStatus
ICS Maugeri - IRCCS of Telese Terme Telese Terme Benevento Recruiting
Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II Naples Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05748015 on ClinicalTrials.gov ↗ ← All trials in Italy